Skip to main content
Erschienen in: World Journal of Surgery 11/2010

01.11.2010

Percutaneous Radiofrequency Ablation versus Partial Hepatectomy for Multicentric Small Hepatocellular Carcinomas: A Nonrandomized Comparative Study

verfasst von: Wei-Xing Guo, Bo Zhai, Eric C. H. Lai, Nan Li, Jie Shi, Wan-Yee Lau, Meng-Chao Wu, Shu-Qun Cheng

Erschienen in: World Journal of Surgery | Ausgabe 11/2010

Einloggen, um Zugang zu erhalten

Abstract

Background

The aim of this study was to compare the results of percutaneous radiofrequency ablation (RFA) with those of partial hepatectomy (PH) in the treatment of multicentric small hepatocellular carcinomas (HCCs). With advances in RFA, it is not known whether the minimally invasive approach with percutaneous RFA could attain comparable survival outcomes but with a lower morbidity in patients with multicentric HCCs.

Methods

From January 2002 and December 2007, 159 patients who had two or three HCCs, with the largest tumor no more than 5 cm in diameter, had no major vascular invasion or extrahepatic metastases, and were treated with either PH (n = 73) or RFA (n = 86) were included in the study.

Results

There was no procedure-related mortality in both groups of patients. Major complications happened significantly more often after PH than after RFA (19.2 vs. 8.1%). The hospital stay was significantly longer after PH than after RFA (median = 9 vs. 3 days). The 1-, 3-, and 5-year overall survival rates for the PH and RFA groups were 91.8, 68.7, 44.5% and 94.2, 64.4, 21.2%, respectively. The corresponding disease-free survival rates for the two groups were 62.1, 33.6, 3.6% and 29.4, 2.7, 0%, respectively. The PH group had significantly longer overall survival and disease-free survival than the RFA group.

Conclusions

PH resulted in better survival outcomes than RFA for patients with multicentric small HCCs. However, RFA had the benefits of lower procedure-related morbidity and shorter hospital stay.
Literatur
1.
Zurück zum Zitat Leong TY, Leong AS (2008) Epidemiology. In: Lau WY (ed) Hepatocellular carcinoma. World Scientific Publishing Co. Pte Ltd, Singapore, pp 1–24CrossRef Leong TY, Leong AS (2008) Epidemiology. In: Lau WY (ed) Hepatocellular carcinoma. World Scientific Publishing Co. Pte Ltd, Singapore, pp 1–24CrossRef
2.
Zurück zum Zitat El-Serag HB, Rudolph KL (2007) Hepatocellular carcinoma: epidemiology and molecular carcinogenesis. Gastroenterology 132:2557–2576CrossRefPubMed El-Serag HB, Rudolph KL (2007) Hepatocellular carcinoma: epidemiology and molecular carcinogenesis. Gastroenterology 132:2557–2576CrossRefPubMed
3.
Zurück zum Zitat Lau WY (2000) Primary hepatocellular carcinoma. In: Blumgart LH, Fong Y (eds) Surgery of the liver and biliary tract, vol II. W. B. Saunders, London, pp 1423–1450 Lau WY (2000) Primary hepatocellular carcinoma. In: Blumgart LH, Fong Y (eds) Surgery of the liver and biliary tract, vol II. W. B. Saunders, London, pp 1423–1450
4.
Zurück zum Zitat Lau WY (2002) Management of hepatocellular carcinoma. J R Coll Surg Edinb 47:389–399PubMed Lau WY (2002) Management of hepatocellular carcinoma. J R Coll Surg Edinb 47:389–399PubMed
5.
Zurück zum Zitat Lau WY, Lai EC (2008) Hepatocellular carcinoma: current management and recent advances. Hepatobiliary Pancreat Dis Int 7:237–257PubMed Lau WY, Lai EC (2008) Hepatocellular carcinoma: current management and recent advances. Hepatobiliary Pancreat Dis Int 7:237–257PubMed
6.
Zurück zum Zitat Lai EC, Lau WY (2005) The continuing challenge of hepatic cancer in Asia. Surgeon 3:210–215CrossRefPubMed Lai EC, Lau WY (2005) The continuing challenge of hepatic cancer in Asia. Surgeon 3:210–215CrossRefPubMed
7.
Zurück zum Zitat Lai EC, Lau WY, Mann DV (2008) Selection of patients for liver resection. In: Lau WY (ed) Hepatocellular carcinoma. World Scientific Publishing Co. Pte Ltd, Singapore, pp 303–316CrossRef Lai EC, Lau WY, Mann DV (2008) Selection of patients for liver resection. In: Lau WY (ed) Hepatocellular carcinoma. World Scientific Publishing Co. Pte Ltd, Singapore, pp 303–316CrossRef
8.
Zurück zum Zitat Lau WY, Leung TW, Yu SC et al (2003) Percutaneous local ablative therapy for hepatocellular carcinoma: a review and look into the future. Ann Surg 237:171–179CrossRefPubMed Lau WY, Leung TW, Yu SC et al (2003) Percutaneous local ablative therapy for hepatocellular carcinoma: a review and look into the future. Ann Surg 237:171–179CrossRefPubMed
9.
Zurück zum Zitat Lau WY, Lai EC (2009) The current role of radiofrequency ablation in the management of hepatocellular carcinoma: a systematic review. Ann Surg 249:20–25CrossRefPubMed Lau WY, Lai EC (2009) The current role of radiofrequency ablation in the management of hepatocellular carcinoma: a systematic review. Ann Surg 249:20–25CrossRefPubMed
10.
Zurück zum Zitat Ho MC, Huang GT, Tsang YM et al (2009) Liver resection improves the survival of patients with multiple hepatocellular carcinomas. Ann Surg Oncol 16:848–855CrossRefPubMed Ho MC, Huang GT, Tsang YM et al (2009) Liver resection improves the survival of patients with multiple hepatocellular carcinomas. Ann Surg Oncol 16:848–855CrossRefPubMed
11.
Zurück zum Zitat Ruzzenente A, Capra F, Pachera S et al (2009) Is liver resection justified in advanced hepatocellular carcinoma? Results of an observational study in 464 patients. J Gastrointest Surg 13:1313–1320CrossRefPubMed Ruzzenente A, Capra F, Pachera S et al (2009) Is liver resection justified in advanced hepatocellular carcinoma? Results of an observational study in 464 patients. J Gastrointest Surg 13:1313–1320CrossRefPubMed
12.
Zurück zum Zitat Liu CL, Fan ST, Lo CM et al (2003) Hepatic resection for bilobar hepatocellular carcinoma: is it justified? Arch Surg 138:100–104CrossRefPubMed Liu CL, Fan ST, Lo CM et al (2003) Hepatic resection for bilobar hepatocellular carcinoma: is it justified? Arch Surg 138:100–104CrossRefPubMed
13.
Zurück zum Zitat Chen MS, Li JQ, Zheng Y et al (2006) A prospective randomized trial comparing percutaneous local ablative therapy and partial hepatectomy for small hepatocellular carcinoma. Ann Surg 243:321–328CrossRefPubMed Chen MS, Li JQ, Zheng Y et al (2006) A prospective randomized trial comparing percutaneous local ablative therapy and partial hepatectomy for small hepatocellular carcinoma. Ann Surg 243:321–328CrossRefPubMed
14.
Zurück zum Zitat Lu MD, Kuang M, Liang LJ et al (2006) Surgical resection versus percutaneous thermal ablation for early-stage hepatocellular carcinoma: a randomized clinical trial. Zhonghua Yi Xue Za Zhi 86(12):801–805PubMed Lu MD, Kuang M, Liang LJ et al (2006) Surgical resection versus percutaneous thermal ablation for early-stage hepatocellular carcinoma: a randomized clinical trial. Zhonghua Yi Xue Za Zhi 86(12):801–805PubMed
15.
Zurück zum Zitat Montorsi M, Santambrogio R, Bianchi P et al (2005) Survival and recurrences after hepatic resection or radiofrequency for hepatocellular carcinoma in cirrhotic patients: a multivariate analysis. J Gastrointest Surg 9:62–67CrossRefPubMed Montorsi M, Santambrogio R, Bianchi P et al (2005) Survival and recurrences after hepatic resection or radiofrequency for hepatocellular carcinoma in cirrhotic patients: a multivariate analysis. J Gastrointest Surg 9:62–67CrossRefPubMed
16.
Zurück zum Zitat Hong SN, Lee SY, Choi MS et al (2005) Comparing the outcomes of radiofrequency ablation and surgery in patients with a single small hepatocellular carcinoma and well-preserved hepatic function. J Clin Gastroenterol 39:247–252CrossRefPubMed Hong SN, Lee SY, Choi MS et al (2005) Comparing the outcomes of radiofrequency ablation and surgery in patients with a single small hepatocellular carcinoma and well-preserved hepatic function. J Clin Gastroenterol 39:247–252CrossRefPubMed
17.
Zurück zum Zitat Lupo L, Panzera P, Giannelli G et al (2007) Single hepatocellular carcinoma ranging from 3 to 5 cm: radiofrequency ablation or resection? HPB (Oxford) 9:429–434 Lupo L, Panzera P, Giannelli G et al (2007) Single hepatocellular carcinoma ranging from 3 to 5 cm: radiofrequency ablation or resection? HPB (Oxford) 9:429–434
18.
Zurück zum Zitat Guglielmi A, Ruzzenente A, Valdegamberi A et al (2008) Radiofrequency ablation versus surgical resection for the treatment of hepatocellular carcinoma in cirrhosis. J Gastrointest Surg 12:192–198CrossRefPubMed Guglielmi A, Ruzzenente A, Valdegamberi A et al (2008) Radiofrequency ablation versus surgical resection for the treatment of hepatocellular carcinoma in cirrhosis. J Gastrointest Surg 12:192–198CrossRefPubMed
Metadaten
Titel
Percutaneous Radiofrequency Ablation versus Partial Hepatectomy for Multicentric Small Hepatocellular Carcinomas: A Nonrandomized Comparative Study
verfasst von
Wei-Xing Guo
Bo Zhai
Eric C. H. Lai
Nan Li
Jie Shi
Wan-Yee Lau
Meng-Chao Wu
Shu-Qun Cheng
Publikationsdatum
01.11.2010
Verlag
Springer-Verlag
Erschienen in
World Journal of Surgery / Ausgabe 11/2010
Print ISSN: 0364-2313
Elektronische ISSN: 1432-2323
DOI
https://doi.org/10.1007/s00268-010-0732-9

Weitere Artikel der Ausgabe 11/2010

World Journal of Surgery 11/2010 Zur Ausgabe

Update Chirurgie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

S3-Leitlinie „Diagnostik und Therapie des Karpaltunnelsyndroms“

Karpaltunnelsyndrom BDC Leitlinien Webinare
CME: 2 Punkte

Das Karpaltunnelsyndrom ist die häufigste Kompressionsneuropathie peripherer Nerven. Obwohl die Anamnese mit dem nächtlichen Einschlafen der Hand (Brachialgia parästhetica nocturna) sehr typisch ist, ist eine klinisch-neurologische Untersuchung und Elektroneurografie in manchen Fällen auch eine Neurosonografie erforderlich. Im Anfangsstadium sind konservative Maßnahmen (Handgelenksschiene, Ergotherapie) empfehlenswert. Bei nicht Ansprechen der konservativen Therapie oder Auftreten von neurologischen Ausfällen ist eine Dekompression des N. medianus am Karpaltunnel indiziert.

Prof. Dr. med. Gregor Antoniadis
Berufsverband der Deutschen Chirurgie e.V.

S2e-Leitlinie „Distale Radiusfraktur“

Radiusfraktur BDC Leitlinien Webinare
CME: 2 Punkte

Das Webinar beschäftigt sich mit Fragen und Antworten zu Diagnostik und Klassifikation sowie Möglichkeiten des Ausschlusses von Zusatzverletzungen. Die Referenten erläutern, welche Frakturen konservativ behandelt werden können und wie. Das Webinar beantwortet die Frage nach aktuellen operativen Therapiekonzepten: Welcher Zugang, welches Osteosynthesematerial? Auf was muss bei der Nachbehandlung der distalen Radiusfraktur geachtet werden?

PD Dr. med. Oliver Pieske
Dr. med. Benjamin Meyknecht
Berufsverband der Deutschen Chirurgie e.V.

S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“

Appendizitis BDC Leitlinien Webinare
CME: 2 Punkte

Inhalte des Webinars zur S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“ sind die Darstellung des Projektes und des Erstellungswegs zur S1-Leitlinie, die Erläuterung der klinischen Relevanz der Klassifikation EAES 2015, die wissenschaftliche Begründung der wichtigsten Empfehlungen und die Darstellung stadiengerechter Therapieoptionen.

Dr. med. Mihailo Andric
Berufsverband der Deutschen Chirurgie e.V.